.Amgen has actually shared (PDF) the very first stage 3 records on its $400 million dermatitis medic...
.Biogen and UCB's gamble on advancing in to phase 3 astride a failed research tries to have paid, al...
.Italian biotech Aptadir Rehabs has introduced with the assurance that its own pipe of preclinical R...
.Surge Life Sciences has met its goal in a Duchenne muscle dystrophy (DMD) study, positioning it to ...
.After a handful of years in biotech, Mike Quigley, Ph.D., is returning to the pharma fold, using up...
.Achilles Rehabs has wrecked its own technique. The British biotech is knocking off on its own clini...
.Aligos Rehabs is heralding a midstage succeed in metabolic-dysfunction affiliated steatohepatitis (...
.Basilea Pharmaceutica's job building new antifungals has actually acquired a considerable increase ...
.Possessing presently gathered up the united state civil rights to Capricor Therapies' late-stage Du...
.After dismissing the decision date for Applied Therapies' metabolic problem drug govorestat, the FD...